Results 241 to 250 of about 522,910 (321)

Efficacy of Once-Nightly Sodium Oxybate in Patients with Narcolepsy: Post Hoc Analyses of Sensitivity, Effect Size, and Numbers Needed to Treat from the Phase 3 REST-ON Trial. [PDF]

CNS Drugs
Roth T, Thorpy MJ, Kushida CA, Gudeman J.   +3 more
europepmc   +1 more source

European Medicines Agency (EMA) commentary on EMA/CHMP Guideline on allergen products development for immunotherapy and allergy diagnosis in moderate to low‐sized study populations

British Journal of Clinical Pharmacology, EarlyView.
Andreas Bonertz, Catherine Drai, Diana Hartenstein, Susanne Kaul, Milica Mitrevski, Jose M. Zubeldia   +5 more
wiley   +1 more source

Rituximab versus placebo for chronic inflammatory demyelinating polyradiculoneuropathy: a randomized trial. [PDF]

Brain
Nobile-Orazio E, Cocito D, Manganelli F, Fazio R, Lauria Pinter G, Benedetti L, Mazzeo A, Peci E, Spina E, Falzone Y, Dalla Bella E, Germano F, Gentile L, Liberatore G, Gallia F, Collet-Vidiella R, Bianchi E, Doneddu PE.   +17 more
europepmc   +1 more source

A Randomized Placebo-Controlled Comparison of Amlodipine and Atenolol in Mild to Moderate Systemic Hypertension

, 1988
William H. Frishman, Richard D. Brobyn, Ronald D. Brown, Brian F. G. Johnson, Robert L. Reeves, Duane G. Wombolt   +5 more
openalex   +1 more source

An open‐label, single‐arm, multicenter, phase II trial of bireociclib as monotherapy for heavily pretreated HR‐positive, HER2‐negative advanced breast cancer patients: BRIGHT‐1 trial

Cancer Communications, EarlyView.
Abstract Background Bireociclib (XZP‐3287) is a novel selective cyclin‐dependent kinase 4 and 6 (CDK4/6) inhibitor, with a favorable safety profile demonstrated in preclinical and phase I studies. BRIGHT‐1 aimed to further explore the efficacy and safety of bireociclib monotherapy in patients with locally advanced, recurrent or metastatic, hormone ...
Jiayu Wang, Qingyuan Zhang, Tao Sun, Huiping Li, Ying Cheng, Zhongsheng Tong, Huihui Li, Wei Li, Jingfen Wang, Yuee Teng, Xinhong Wu, Jing Cheng, Zhendong Chen, Zhengqiu Zhu, Li Wang, Mingming Liu, Xianghui Duan, Lingmei Xu, Binghe Xu   +18 more
wiley   +1 more source

Challenges of blinding in clinical balneology trials: a scoping review. [PDF]

BMC Complement Med Ther
Szendi K, Lohner S, Szenczi Á, Murányi E, Berényi K, Németh B.   +5 more
europepmc   +1 more source

Effect of Tadalafil on cardiac function and left ventricular dimensions in Duchenne muscular dystrophy: safety and cardiac MRI substudy results from a randomized, placebo-controlled trial. [PDF]

BMC Cardiovasc Disord
Cox D, Byrne B, Hammers DW, Landry J, Sweeney HL.   +4 more
europepmc   +1 more source

Correction to: Acacia fiber or probiotic supplements to relieve gastrointestinal complaints in patients with constipation-predominant IBS: a 4-week randomized double-blinded placebo-controlled intervention trial. [PDF]

Eur J Nutr
JanssenDuijghuijsen L, Belt MVD, Rijnaarts I, Vos P, Guillemet D, Witteman B, Wit N.   +6 more
europepmc   +1 more source

Structural, Spectroscopic, and Docking Analysis of N,O‐Donor Ligand Metal Complex Nanoparticles With Hypolipidemic Effects via Lipoprotein Lipase Activation in High‐Fat Diet Mice

Chemistry &Biodiversity, EarlyView.
Hypolipidemic influence of CETZ.2HCl‐(H1‐antihistamine) metal‐complexes on “C57Bl/6‐mice” fed high‐fat‐diet. ABSTRACT New Cd(II), Zn(II), and Cu(II) chelates with cetirizine.2HCl (CETZ.2HCl) in incidence of 1,10 phenanthroline monohydrate (Phen.H2O) were synthesized in search of new biologically active compounds.
Sherif M. Abd El‐Hamid, Safa W. Aziz, Amira A. Mohamed, Mohammed S. El‐Gedamy, Ahmed E. Salem, Soha F. Mohammed, Wael A. Zordok, Adriano Sofo, Mohamed A. Sabry, Sadeek A. Sadeek, Hazem S. Elshafie   +10 more
wiley   +1 more source

The efficacy of cannabidiol for seizures reduction in pharmacoresistant epilepsy: a systematic review and meta-analysis. [PDF]

Acta Epileptol
de Oliveira VG, de Almeida NB, Radmann GC, de Oliveira Santos BF.   +3 more
europepmc   +1 more source